for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eli Lilly applies for FDA emergency use authorization for COVID-19 treatment

Oct 7 (Reuters) - Eli Lilly and Co said on Wednesday it had submitted a request to the U.S. Food and Drug Administration for emergency use of its experimental antibody treatment for COVID-19.

Separately, the U.S. drugmaker said data from a new study showed a combination of two of its antibody treatments helped reduce hospitalization and emergency room visits for COVID-19 patients. (Reporting by Manas Mishra in Bengaluru; Editing by Ramakrishnan M.)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up